The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/akt signaling

Circulation Research

Volumn 111, Issue 10, 2012, Pages 1297-1307

  Borst, Oliver ^a   Münzer, Patrick ^a   Gatidis, Sergios ^a   Schmidt, Eva Maria ^a   Schönberger, Tanja ^a   Schmid, Evi ^a   Towhid, Syeda T ^a   Stellos, Konstantinos ^a   Seizer, Peter ^a   May, Andreas E ^a   Lang, Florian ^a   Gawaz, Meinrad ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

CXC motif ligand 16; CXC motif receptor 6; inflammation; phosphatidylinositide 3 kinase Akt; platelet activation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALPHAIIBBETA3 INTEGRIN; APYRASE; CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; INTEGRIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PURINERGIC P2Y1 RECEPTOR; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; BLOOD VESSEL WALL; CAROTID ARTERY LIGATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEGRANULATION; ENDOTHELIUM; FLOW CYTOMETRY; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEAR STRESS; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; WESTERN BLOTTING;

ANIMALS; BENZOFURANS; BLOOD PLATELETS; CHEMOKINE CXCL6; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MICE; MICE, MUTANT STRAINS; PHOSPHATIDYLINOSITOL 3-KINASES; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PROTO-ONCOGENE PROTEINS C-AKT; QUINOLINES; RECEPTORS, CXCR; SIGNAL TRANSDUCTION; THROMBOSIS; VASCULITIS;

EID: 84868699503     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.276444     Document Type: Article

References (60)

1. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8: 1227-1234. (Pubitemid 35373553)
2. Borst O, Schmidt EM, Münzer P, Schönberger T, Towhid ST, Elvers M, Leibrock C, Schmid E, Eylenstein A, Kuhl D, May AE, Gawaz M, Lang F. The serum-and glucocorticoid-inducible kinase 1 (SGK1) infuences platelet calcium signaling and function by regulation of Orai1 expression in megakaryocytes. Blood. 2012;119:251-261.
3. Varga-Szabo D, Braun A, Nieswandt B. Calcium signaling in platelets. J Thromb Haemost. 2009;7:1057-1066.
4. Langer HF, Choi EY, Zhou H, et al. Platelets contribute to the patho-genesis of experimental autoimmune encephalomyelitis. Circ Res. 2012;110:1202-1210.
5. Gawaz M, Langer H, May AE. Platelets in infammation and atherogenesis. J Clin Invest. 2005;115:3378-3384.
6. May AE, Seizer P, Gawaz M. Platelets: infammatory frebugs of vascular walls. Arterioscler Thromb Vasc Biol. 2008;28:s5-10.
7. Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, Koch W, Schömig A, Neumann F. Platelets induce alterations of che-motactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis. 2000;148:75-85.
8. Massberg S, Konrad I, Schürzinger K, et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med. 2006;203:1221-1233. (Pubitemid 43736592)
9. Stellos K, Langer H, Daub K, et al. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation. 2008;117:206-215.
10. Jansson AM, Aukrust P, Ueland T, Smith C, Omland T, Hartford M, Caidahl K. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes. Circulation. 2009;119:3181-3188.
11. Aukrust P, Halvorsen B, Yndestad A, Ueland T, Øie E, Otterdal K, Gullestad L, Damås JK. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol. 2008;28:1909-1919.
12. Zernecke A, Weber C. Chemokines in the vascular infammatory response of atherosclerosis. Cardiovasc Res. 2010;86:192-201.
13. Lambert MP, Sachais BS, Kowalska MA. Chemokines and thromboge-nicity. Thromb Haemost. 2007;97:722-729.
14. Gleissner CA, von Hundelshausen P, Ley K. Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol. 2008;28:1920-1927.
15. Darash-Yahana M, Gillespie JW, Hewitt SM, Chen Y Y, Maeda S, Stein I, Singh S P, Bedolla RB, Peled A, Troyer DA, Pikarsky E, Karin M, Farber JM. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of infammation-associated cancers. PLoS ONE. 2009;4:e6695.
16. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol. 2000;1:298-304.
17. Sheikine Y, Sirsjö A. CXCL16/SR-PSOX-a friend or a foe in atherosclerosis? Atherosclerosis. 2008;197:487-495.
18. Chandrasekar B, Bysani S, Mummidi S. CXCL16 signals via Gi, phos-phatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem. 2004;279:3188-3196. (Pubitemid 38140551)
19. Galkina E, Harry BL, Ludwig A, Liehn EA, Sanders JM, Bruce A, Weber C, Ley K. CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall. Circulation. 2007;116:1801-1811. (Pubitemid 350287105)
20. Wang J, Lu Y, Wang J, Koch AE, Zhang J, Taichman RS. CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway. Cancer Res. 2008;68:10367-10376.
21. Petit SJ, Wise EL, Chambers JC, Sehmi J, Chayen NE, Kooner JS, Pease JE. The CXCL16 A181V mutation selectively inhibits monocyte adhesion to CXCR6 but is not associated with human coronary heart disease. Arterioscler Thromb Vasc Biol. 2011;31:914-920.
22. Minami M, Kume N, Shimaoka T, Kataoka H, Hayashida K, Akiyama Y, Nagata I, Ando K, Nobuyoshi M, Hanyuu M, Komeda M, Yonehara S, Kita T. Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2001;21:1796-1800. (Pubitemid 34219784)
23. Shimaoka T, Kume N, Minami M, Hayashida K, Kataoka H, Kita T, Yonehara S. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem. 2000;275:40663-40666. (Pubitemid 32054881)
24. Borst O, Abed M, Alesutan I, Towhid ST, Qadri SM, Föller M, Gawaz M, Lang F. Dynamic adhesion of eryptotic erythrocytes to en-dothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol. 2012;302:C644-C651.
25. Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, Schuster B, Kallen KJ, Saftig P, Rose-John S, Ludwig A. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol. 2004;172:6362-6372. (Pubitemid 38621245)
26. Aslanian AM, Charo IF. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation. 2006;114:583-590. (Pubitemid 44199648)
27. Seizer P, Stellos K, Selhorst G, Krämer BF, Lang MR, Gawaz M, May AE. CXCL16 is a novel scavenger receptor on platelets and is associated with acute coronary syndrome. Thromb Haemost. 2011;105:1112-1114.
28. Lehrke M, Millington SC, Lefterova M, Cumaranatunge RG, Szapary P, Wilensky R, Rader DJ, Lazar MA, Reilly MP. CXCL16 is a marker of infammation, atherosclerosis, and acute coronary syndromes in humans. J Am Coll Cardiol. 2007;49:442-449. (Pubitemid 46135882)
29. Mitsuoka H, Toyohara M, Kume N, Hayashida K, Jinnai T, Tanaka M, Kita T. Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome-comparison with high-sensitivity C-reactive protein. J Atheroscler Thromb. 2009;16:586-593.
30. Yin H, Stojanovic A, Hay N, Du X. The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation. Blood. 2008;111:658-665.
31. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem. 2001;276:38349-38352.
32. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 2001;292:1728-1731. (Pubitemid 32506248)
33. Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M, Vestweber D, Massberg S, Schönberger T, Pfsterer I, Hatzopoulos AK, Gawaz M. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res. 2006;98:e2-10.
34. Massberg S, Schürzinger K, Lorenz M, Konrad I, Schulz C, Plesnila N, Kennerknecht E, Rudelius M, Sauer S, Braun S, Kremmer E, Emambokus NR, Frampton J, Gawaz M. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation. 2005;112:1180-1188. (Pubitemid 41216125)
35. Lu Y, Wang J, Xu Y, Koch AE, Cai Z, Chen X, Galson DL, Taichman RS, Zhang J. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro. Mol Cancer Res. 2008;6:546-554. (Pubitemid 351521836)
36. Weber C. Platelets and chemokines in atherosclerosis: partners in crime. Circ Res. 2005;96:612-616. (Pubitemid 40478327)
37. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp BK, Piccinini AM, Paludan SR, Kowalska MA, Kungl AJ, Hackeng TM, Mayo KH, Weber C. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyper-lipidemic mice. Nat Med. 2009;15:97-103.
38. Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol. 2008;28:1897-1908.
39. Wilbanks A, Zondlo SC, Murphy K, Mak S, Soler D, Langdon P, Andrew DP, Wu L, Briskin M. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol. 2001;166:5145-5154. (Pubitemid 32280729)
40. Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates frm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol. 2004;75:267-274. (Pubitemid 38174584)
41. Stojanovic A, Marjanovic JA, Brovkovych VM, Peng X, Hay N, Skidgel RA, Du X. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation. J Biol Chem. 2006;281:16333-16339.
42. Woulfe DS. Akt signaling in platelets and thrombosis. Expert Rev Hematol. 2010;3:81-91.
43. Kim S, Jin J, Kunapuli SP. Akt activation in platelets depends on Gi signaling pathways. J Biol Chem. 2004;279:4186-4195. (Pubitemid 38199005)
44. Chen J, De S, Damron DS, Chen WS, Hay N, Byzova TV. Impaired platelet responses to thrombin and collagen in AKT-1-defcient mice. Blood. 2004;104:1703-1710. (Pubitemid 39202277)
45. Woulfe D, Jiang H, Morgans A, Monks R, Birnbaum M, Brass LF. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest. 2004;113:441-450. (Pubitemid 38544188)
46. Wuttge DM, Zhou X, Sheikine Y, Wågsäter D, Stemme V, Hedin U, Stemme S, Hansson GK, Sirsjö A. CXCL16/SR-PSOX is an interferon-gamma- regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2004;24:750-755. (Pubitemid 38451615)
47. Hofnagel O, Engel T, Severs NJ, Robenek H, Buers I. SR-PSOX at sites predisposed to atherosclerotic lesion formation mediates mono-cyte-endothelial cell adhesion. Atherosclerosis. 2011;217:371-378.
48. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K. Circulating activated platelets exacerbate atherosclerosis in mice defcient in apolipoprotein E. Nat Med. 2003;9:61-67. (Pubitemid 36098261)
49. Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood. 2003;101:2661-2666. (Pubitemid 36857627)
50. Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med. 1998;187:329-339. (Pubitemid 28080062)
51. Massberg S, Brand K, Grüner S, Page S, Müller E, Müller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196:887-896.
52. Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res. 2000;86:131-138. (Pubitemid 30086172)
53. Gear AR, Suttitanamongkol S, Viisoreanu D, Polanowska-Grabowska RK, Raha S, Camerini D. Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood. 2001;97:937-945. (Pubitemid 32154277)
54. Kowalska MA, Ratajczak MZ, Majka M, Jin J, Kunapuli S, Brass L, Poncz M. Stromal cell-derived factor-1 and macrophage-derived chemo-kine: 2 chemokines that activate platelets. Blood. 2000;96:50-57. (Pubitemid 30456449)
55. Schäfer A, Schulz C, Eigenthaler M, Fraccarollo D, Kobsar A, Gawaz M, Ertl G, Walter U, Bauersachs J. Novel role of the membrane-bound che-mokine fractalkine in platelet activation and adhesion. Blood. 2004;103: 407-412. (Pubitemid 38140067)
56. Andre P, Delaney SM, LaRocca T, Vincent D, DeGuzman F, Jurek M, Koller B, Phillips DR, Conley PB. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest. 2003;112:398-406. (Pubitemid 38063768)
57. Léon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave JP, Gachet C. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest. 1999;104:1731-1737. (Pubitemid 30053190)
58. Remijn JA, Wu YP, Jeninga EH, IJsseldijk MJ, van Willigen G, de Groot PG, Sixma JJ, Nurden AT, Nurden P. Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in fowing blood. Arterioscler Thromb Vasc Biol. 2002;22:686-691. (Pubitemid 34408754)
59. Cosemans JM, Munnix IC, Wetzker R, Heller R, Jackson SP, Heemskerk JW. Continuous signaling via PI3K isoforms beta and gamma is required for platelet ADP receptor function in dynamic thrombus stabilization. Blood. 2006;108:3045-3052.
60. Kim S, Mangin P, Dangelmaier C, Lillian R, Jackson SP, Daniel JL, Kunapuli SP. Role of phosphoinositide 3-kinase beta in gly-coprotein VI-mediated Akt activation in platelets. J Biol Chem. 2009;284:33763-33772.